Energy-based therapies have a variety of applications to CV disease—the number one killer in most of the world. When the heart has to work too hard to maintain adequate blood output, it can begin to change shape, with the left ventricle (the heart’s main pumping chamber) often growing larger, less flexible and weaker. Prolonged compensation for these impairments can change both the heart structure and its function. Remodeling of the heart results in errant signals transmitted from the SA node that cause unsynchronized heart beats. These are treatable with a variety of energy-based therapies including implantable resynchronization devices and surgical ablation therapies. Energy is also being employed in the fight against CV disease as a means to open occluded vessels and revascularize damaged heart muscles.
Source: MedMarket Diligence, LLC; ,, "Ablation Technologies Worldwide Market, 2008-2017."